Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Medtronic
MDT
|
+$464M |
| 2 |
Exxon Mobil
XOM
|
+$299M |
| 3 |
FedEx
FDX
|
+$289M |
| 4 |
Netflix
NFLX
|
+$273M |
| 5 |
Micron Technology
MU
|
+$265M |
Top Sells
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
Electronic Arts
EA
|
+$285M |
| 3 |
Mastercard
MA
|
+$269M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$237M |
Sector Composition
| 1 | Healthcare | 15.71% |
| 2 | Technology | 15.39% |
| 3 | Financials | 11.4% |
| 4 | Industrials | 9.47% |
| 5 | Consumer Staples | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Riverview Bancorp
RVSB
$102M
| $1.3M | ﹤0.01% |
154,200
+28,000
| +22% | +$235K |
|
2477
Air Lease Corp
AL
$7.1B
| $1.29M | ﹤0.01% |
30,200
-20,710
| -41% | -$883K |
|
2478
Inuvo
INUV
$50.1M
| $1.29M | ﹤0.01% |
129,372
+2,510
| +2% | +$25K |
|
|
IMDZ
2479
DELISTED
Immune Design Corp.
IMDZ
| $1.28M | ﹤0.01% |
123,591
-16,209
| -12% | -$168K |
|
2480
Westlake Chemical Partners
WLKP
$763M
| $1.28M | ﹤0.01% |
56,289
-2,132
| -4% | -$48.4K |
|
2481
Asbury Automotive
ABG
$4.8B
| $1.28M | ﹤0.01% |
20,904
+5,804
| +38% | +$355K |
|
|
PRSS
2482
DELISTED
CafePress Inc.
PRSS
| $1.27M | ﹤0.01% |
702,325
+41,625
| +6% | +$75.3K |
|
2483
Live Oak Bancshares
LOB
$1.67B
| $1.27M | ﹤0.01% |
+54,157
| New | +$1.27M |
|
|
SEI
2484
Solaris Energy Infrastructure, Inc.
SEI
$1.39B
| $1.27M | ﹤0.01% |
+72,800
| New | +$1.27M |
|
|
CETV
2485
DELISTED
Central European Media Enterprises Ltd
CETV
| $1.27M | ﹤0.01% |
313,279
+198,800
| +174% | +$805K |
|
2486
Summit Therapeutics
SMMT
$14.1B
| $1.27M | ﹤0.01% |
101,000
+62,500
| +162% | +$785K |
|
2487
Amplify Energy
AMPY
$160M
| $1.27M | ﹤0.01% |
81,400
-2,100
| -3% | -$32.6K |
|
2488
EVI Industries
EVI
$348M
| $1.26M | ﹤0.01% |
45,700
-24,800
| -35% | -$686K |
|
|
MSBF
2489
DELISTED
MSB Financial Corp.
MSBF
| $1.26M | ﹤0.01% |
70,600
+4,100
| +6% | +$73.2K |
|
|
DVCR
2490
DELISTED
Diversicare Healthcare Services Inc
DVCR
| $1.26M | ﹤0.01% |
109,300
+2,500
| +2% | +$28.8K |
|
2491
Smith & Nephew
SNN
$16.4B
| $1.26M | ﹤0.01% |
34,500
-89,200
| -72% | -$3.25M |
|
2492
Telefônica Brasil
VIV
$20B
| $1.26M | ﹤0.01% |
79,253
-261,300
| -77% | -$4.14M |
|
|
KSPN
2493
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
| $1.25M | ﹤0.01% |
31,305
+155
| +0.5% | +$6.2K |
|
2494
Lantronix
LTRX
$174M
| $1.25M | ﹤0.01% |
513,866
+48,900
| +11% | +$119K |
|
|
FBMS
2495
DELISTED
The First Bancshares, Inc.
FBMS
| $1.23M | ﹤0.01% |
40,930
+2,730
| +7% | +$82.3K |
|
2496
Tejon Ranch
TRC
$448M
| $1.22M | ﹤0.01% |
+59,740
| New | +$1.22M |
|
2497
WisdomTree
WT
$2.11B
| $1.22M | ﹤0.01% |
+120,200
| New | +$1.22M |
|
|
JCTC
2498
Jewett-Cameron Trading
JCTC
$12.7M
| $1.22M | ﹤0.01% |
176,000
+1,000
| +0.6% | +$6.94K |
|
2499
Upbound Group
UPBD
$1.45B
| $1.22M | ﹤0.01% |
106,310
-5,800
| -5% | -$66.6K |
|
2500
Protalix BioTherapeutics
PLX
$144M
| $1.22M | ﹤0.01% |
210,130
-19,950
| -9% | -$116K |
|